{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg6b00488.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>As\nmore prescription and over-the-counter drugs are consumed worldwide,\nmore and more drugs and their metabolites are entering the water stream\nwith a water purification infrastructure not designed for their removal.\nEventually this problem in conjunction with increasing amounts of\nindustrially related waste organic molecules (i.e., PAHs) could lead\nto largescale water contamination. Herein we report a new perfluorinated\nIn-derived metal\u2013organic framework entitled YCM-101 synthesized\nfrom InCl<sub>3</sub> and tetrafluoroterephthalic acid. YCM-101 is\ncapable of removing the antibiotic tetracycline from aqueous solution,\nputatively accomplished via \u03c0\u2013\u03c0 stacking interactions\nof the electron deficient MOF linker and the electron rich aromatic\ncomponents of tetracycline. This hypothesis was supported by obtained\ncrystal structures of both benzene and pyridine participating in \u03c0\u2013\u03c0\nstacking with YCM-101.</p>", "clean_text": "As more prescription and over-the-counter drugs are consumed worldwide, more and more drugs and their metabolites are entering the water stream with a water purification infrastructure not designed for their removal. Eventually this problem in conjunction with increasing amounts of industrially related waste organic molecules (i.e., PAHs) could lead to largescale water contamination. Herein we report a new perfluorinated In-derived metal-organic framework entitled YCM-101 synthesized from InCl3 and tetrafluoroterephthalic acid. YCM-101 is capable of removing the antibiotic tetracycline from aqueous solution, putatively accomplished via \u03c0-\u03c0 stacking interactions of the electron deficient MOF linker and the electron rich aromatic components of tetracycline. This hypothesis was supported by obtained crystal structures of both benzene and pyridine participating in \u03c0-\u03c0 stacking with YCM-101.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>A new indium-derived perfluorinated metal\u2212organic\nframework (YCM-101) is reported. It is demonstrated that YCM-101 has\na significant ability to participate in \u03c0\u2212\u03c0 stacking\ninteractions with benzene, pyridine, and the antibiotic tetracycline.\nIt is believed that this class of frameworks has the potential for\ndownstream applications in bulk water purification for the removal\nof pharmaceuticals and polycyclic aromatic hydrocarbons.</p>", "clean_text": "A new indium-derived perfluorinated metal-organic framework (YCM-101) is reported. It is demonstrated that YCM-101 has a significant ability to participate in \u03c0-\u03c0 stacking interactions with benzene, pyridine, and the antibiotic tetracycline. It is believed that this class of frameworks has the potential for downstream applications in bulk water purification for the removal of pharmaceuticals and polycyclic aromatic hydrocarbons.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Access to potable water\nremains a challenge not just for developing\ncountries but also for the developed world. Due to industrialization\nand advances in medicine, many water bodies in North America, Europe,\nand Australia are contaminated with polycyclic aromatic hydrocarbons\n(PAHs) and pharmaceuticals at levels ranging from low ppb\nto low ppm. PAHs enter the water economy via vehicle exhaust, industrial and asphalt sealant runoff, and atmospheric deposition; as well as catastrophic occurrences such as the Deep Water\nHorizon spill. Chronic exposure to PAHs has been linked to carcinogenesis and genotoxicity. Pharmaceuticals and their metabolites, predominantly antibiotics\nand hormones, access the water stream via excretion from human and\nveterinary patients after drug consumption. Although the long-term\nside effects of low level chronic exposure of pharmaceuticals to humans\nremains to be elucidated, the effect on aquatic life in contaminated\nareas has been demonstrated. Environmentally\nrelevant levels of ciprofloxacin (an antibiotic) have led to decreased\ngrowth in plankton and algae, and \u03b1-ethinylestradiol\n(a contraceptive) has led to feminization and decreased life expectancy\nin lake trout and other fresh water fish. Other potential side effects of increased levels of antibiotics\nin water bodies include the creation of antibiotic-resistant bacteria\nthat can lead to indirect effects such as bacterial outbreaks. Common water treatment techniques (traditionally\ndesigned for parasite and microbe removal) such as the activated sludge\nprocess are capable of removing some of these contaminants from water\nstreams; however, batch and site disparities in sludge quality have\nled to mixed results.\n</p>", "clean_text": "Introduction\n\nAccess to potable water remains a challenge not just for developing countries but also for the developed world. Due to industrialization and advances in medicine, many water bodies in North America, Europe, and Australia are contaminated with polycyclic aromatic hydrocarbons (PAHs) and pharmaceuticals at levels ranging from low ppb to low ppm. PAHs enter the water economy via vehicle exhaust, industrial and asphalt sealant runoff, and atmospheric deposition; as well as catastrophic occurrences such as the Deep Water Horizon spill. Chronic exposure to PAHs has been linked to carcinogenesis and genotoxicity. Pharmaceuticals and their metabolites, predominantly antibiotics and hormones, access the water stream via excretion from human and veterinary patients after drug consumption. Although the long-term side effects of low level chronic exposure of pharmaceuticals to humans remains to be elucidated, the effect on aquatic life in contaminated areas has been demonstrated. Environmentally relevant levels of ciprofloxacin (an antibiotic) have led to decreased growth in plankton and algae, and \u03b1-ethinylestradiol (a contraceptive) has led to feminization and decreased life expectancy in lake trout and other fresh water fish. Other potential side effects of increased levels of antibiotics in water bodies include the creation of antibiotic-resistant bacteria that can lead to indirect effects such as bacterial outbreaks. Common water treatment techniques (traditionally designed for parasite and microbe removal) such as the activated sludge process are capable of removing some of these contaminants from water streams; however, batch and site disparities in sludge quality have led to mixed results. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>An emerging and attractive alternative for water purification\nis\nthe use of hydrophobic fluorinated metal\u2013organic frameworks\n(MOFs) as an adsorbent for organic small molecules. Recently Miljanic\u0301 has shown that highly fluorinated\nCu-derived MOFF-5 is competent for gas or vapor phase sorption of\nperfluorinated alkanes, perfluorocarbons, and hydrocarbons. Omary has also demonstrated that perfluorinated\nFMOF-1 can adsorb hydrocarbons including arenes in the vapor phase. To our knowledge, little work has been focused\non aqueous phase extraction of organic molecules using highly fluorinated or perfluorinated MOFs. We hypothesized that perfluorinated-aromatic MOFs would be attractive\nfor this application as (1) it has been demonstrated that several\nperfluorinated MOFs are water-repellant in both the liquid and gas\nphases and (2) the electron deficient aromatic\nlinkers of perfluorinated MOFs could lead to beneficial \u03c0\u2013\u03c0\nstacking interactions with electron rich arenes (a common functional\ngroup in PAHs and many pharmaceuticals). It is worth\nnoting that Dichtel has recently reported a similar approach utilizing\nperfluorinated cross-linkages in \u03b2-cyclodextrin polymers to\naffect the removal of organic pollutants from water. Herein we report the synthesis of a new perfluorinated\nIn-derived MOF, YCM-101 (YCM = Youngstown Crystalline Material), and\nits ability to bind benzene via \u03c0\u2013\u03c0 stacking and\nits application in the removal of tetracycline from aqueous solution.</p>", "clean_text": "An emerging and attractive alternative for water purification is the use of hydrophobic fluorinated metal-organic frameworks (MOFs) as an adsorbent for organic small molecules. Recently Miljanic\u0301 has shown that highly fluorinated Cu-derived MOFF-5 is competent for gas or vapor phase sorption of perfluorinated alkanes, perfluorocarbons, and hydrocarbons. Omary has also demonstrated that perfluorinated FMOF-1 can adsorb hydrocarbons including arenes in the vapor phase. To our knowledge, little work has been focused on aqueous phase extraction of organic molecules using highly fluorinated or perfluorinated MOFs. We hypothesized that perfluorinated-aromatic MOFs would be attractive for this application as (1) it has been demonstrated that several perfluorinated MOFs are water-repellant in both the liquid and gas phases and (2) the electron deficient aromatic linkers of perfluorinated MOFs could lead to beneficial \u03c0-\u03c0 stacking interactions with electron rich arenes (a common functional group in PAHs and many pharmaceuticals). It is worth noting that Dichtel has recently reported a similar approach utilizing perfluorinated cross-linkages in \u03b2-cyclodextrin polymers to affect the removal of organic pollutants from water. Herein we report the synthesis of a new perfluorinated In-derived MOF, YCM-101 (YCM = Youngstown Crystalline Material), and its ability to bind benzene via \u03c0-\u03c0 stacking and its application in the removal of tetracycline from aqueous solution.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<title>Experimental Section</title><title>General</title><p>InCl<sub>3</sub> was purchased from Alfa Aesar,\ntetrafluoroterephthalic acid and tetracycline-HCl were purchased from\nSigma-Aldrich, DCl and CD<sub>3</sub>OD were purchased from Cambridge\nIsotope Laboratories, and all solvents were purchased from Acros.\nAll reagents were used as received.</p>", "clean_text": "Experimental Section\n\nGeneral\n\nInCl3 was purchased from Alfa Aesar, tetrafluoroterephthalic acid and tetracycline-HCl were purchased from Sigma-Aldrich, DCl and CD3OD were purchased from Cambridge Isotope Laboratories, and all solvents were purchased from Acros. All reagents were used as received.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of YCM-101</title><p>To a premixed solution of DMF\n(4.75 mL), 2-propanol (85.50 mL), and deionized water (4.75 mL) was\nadded 2,3,5,6-tetrafluoroterephthalic acid (0.595 g, 2.50 mmol, 1.00\nequiv) and InCl<sub>3</sub> (1.10 g, 5.00 mmol, 2.00 equiv) in that\norder. The resulting solution was sonicated for 6\u20137 min until\ncomplete dissolution was observed. The solution sat in a hood for\n30 min covered with Parafilm, which was determined to produce larger\ncrystals than no wait period. The clear solution was then filtered\nthrough a GE-brand 25 mm PVDF syringe filter in 5 mL portions into\n20 mL scintillation vials. The scintillation vials were sealed with\nTeflon-lined caps and placed in an 80 \u00b0C oven for 72 h. The vials\nwere removed from the oven and allowed to cool to room temperature.\nThe cubic, colorless crystals were combined into one 4 mL vial by\ndrawing up both crystals and mother liquor using a pipet. The mother\nliquor was decanted away from the crystals, which were then washed\nwith DMF (3 \u00d7 2 mL). Crystals of YCM-101 washed with DMF (3 \u00d7\n2 mL) were dried under high vacuum at room temperature for a minimum\nof 18 h yielding \u201cactivated YCM-101\u201d.</p>", "clean_text": "Synthesis of YCM-101\n\nTo a premixed solution of DMF (4.75 mL), 2-propanol (85.50 mL), and deionized water (4.75 mL) was added 2,3,5,6-tetrafluoroterephthalic acid (0.595 g, 2.50 mmol, 1.00 equiv) and InCl3 (1.10 g, 5.00 mmol, 2.00 equiv) in that order. The resulting solution was sonicated for 6-7 min until complete dissolution was observed. The solution sat in a hood for 30 min covered with Parafilm, which was determined to produce larger crystals than no wait period. The clear solution was then filtered through a GE-brand 25 mm PVDF syringe filter in 5 mL portions into 20 mL scintillation vials. The scintillation vials were sealed with Teflon-lined caps and placed in an 80 \u00b0C oven for 72 h. The vials were removed from the oven and allowed to cool to room temperature. The cubic, colorless crystals were combined into one 4 mL vial by drawing up both crystals and mother liquor using a pipet. The mother liquor was decanted away from the crystals, which were then washed with DMF (3 \u00d7 2 mL). Crystals of YCM-101 washed with DMF (3 \u00d7 2 mL) were dried under high vacuum at room temperature for a minimum of 18 h yielding \"activated YCM-101\".", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<title>Doping of\nYCM-101 with Tetracycline HCl</title><p>To a 4 mL vial\ncontaining 2.00 mL of water was added tetracycline HCl (0.020 g, 0.042\nmmol, 1.00 equiv). The solution was manually shaken until dissolution\nwas observed. Activated YCM-101 (0.0500 g) was then added to the golden\nyellow solution. The vial was placed on a Thermo Scientific MaxQ 2000\nshaker (\u223c100 rpm) for 5 days. The yellow crystals were rinsed\nwith water (3 \u00d7 2 mL); the second rinse portion was used to transfer\nthe crystals to a new 4 mL vial, and the crystals soaked in the third\nportion overnight. The entire batch of yellow crystals were digested\nusing a 1:1 mixture by volume of DCl/CD<sub>3</sub>OD (3.00 mL). The\nresulting solution was then analyzed using <sup>1</sup>H NMR spectroscopy\nusing dichloromethane (2.7 \u03bcL, 0.042 mmol, 1.0 equiv) as a standard.\nThe amount of tetracycline uptake was determined by comparison of\nthe relative peak integrations of the aromatic tetracycline peak at\n7.64 ppm versus that of dichloromethane standard at 5.48 ppm.</p>", "clean_text": "Doping of YCM-101 with Tetracycline HCl\n\nTo a 4 mL vial containing 2.00 mL of water was added tetracycline HCl (0.020 g, 0.042 mmol, 1.00 equiv). The solution was manually shaken until dissolution was observed. Activated YCM-101 (0.0500 g) was then added to the golden yellow solution. The vial was placed on a Thermo Scientific MaxQ 2000 shaker (~100 rpm) for 5 days. The yellow crystals were rinsed with water (3 \u00d7 2 mL); the second rinse portion was used to transfer the crystals to a new 4 mL vial, and the crystals soaked in the third portion overnight. The entire batch of yellow crystals were digested using a 1:1 mixture by volume of DCl/CD3OD (3.00 mL). The resulting solution was then analyzed using 1H NMR spectroscopy using dichloromethane (2.7 \u03bcL, 0.042 mmol, 1.0 equiv) as a standard. The amount of tetracycline uptake was determined by comparison of the relative peak integrations of the aromatic tetracycline peak at 7.64 ppm versus that of dichloromethane standard at 5.48 ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": "error", "content": "<title>Results and Discussion</title><p>Treatment of InCl<sub>3</sub> with\n2,3,5,6-tetrafluoro-1,4-dicarboxylic\nacid (perfluorinated terephthalic acid) in a mixture of DMF/<italic>i</italic>-PrOH/water (1:18:1) at 80 \u00b0C yielded the new In-derived\nperfluorinated MOF YCM-101. To our knowledge YCM-101 represents the\nfirst indium-derived perfluorinated MOF in the literature. YCM-101\nis a three-dimensional neutral MOF containing an [In\u00ad(\u03bc-O<sub>2</sub>CR)<sub>2</sub>(\u03bc-OH)]<sub>\u221e</sub> infinite chain\nsecondary building unit (SBU), where each bridging organic ligand\nis linked to two distinct SBUs (). Crystallographically, the as-synthesized material\ncontains disordered DMF molecules and no detectable <italic>i</italic>-PrOH or water. PLATON calculations yield a solvent accessible void\nvolume of 873 \u00c5<sup>3</sup> accounting for 50% of the total volume\nof the structure. Notably the perfluorinated linkers are rotated \u223c90\n\u00b0C compared to their proteo-counterparts, a feature common to\nperfluorinated MOFs. The MOF is porous in all three Cartesian axes, containing an accessible\nwindow of 5.7 \u00d7 5.7 \u00c5, which accounts for the protrusion\nof fluorine into the apertures due to the above-mentioned linker rotation.\nYCM-101 is isoreticular with our previously reported YCM-23, derived\nfrom 2,5-thiophene dicarboxylic acid and InCl<sub>3</sub>; however, it is topologically distinct from MIL-68-In, synthesized from terephthalic acid and containing an identical infinite\nchain SBU. Like YCM-23, YCM-101 suffers from stability issues upon\ncomplete removal of solvent from the pores. The obtained BET surface\nareas were inconsistent and irreproducible, ranging from 50 to 200\nm<sup>2</sup>/g.</p>", "clean_text": "Results and Discussion\n\nTreatment of InCl3 with 2,3,5,6-tetrafluoro-1,4-dicarboxylic acid (perfluorinated terephthalic acid) in a mixture of DMF/i-PrOH/water (1:18:1) at 80 \u00b0C yielded the new In-derived perfluorinated MOF YCM-101. To our knowledge YCM-101 represents the first indium-derived perfluorinated MOF in the literature. YCM-101 is a three-dimensional neutral MOF containing an [In(\u03bc-O2CR)2(\u03bc-OH)]\u221e infinite chain secondary building unit (SBU), where each bridging organic ligand is linked to two distinct SBUs (). Crystallographically, the as-synthesized material contains disordered DMF molecules and no detectable i-PrOH or water. PLATON calculations yield a solvent accessible void volume of 873 \u00c53 accounting for 50% of the total volume of the structure. Notably the perfluorinated linkers are rotated ~90 \u00b0C compared to their proteo-counterparts, a feature common to perfluorinated MOFs. The MOF is porous in all three Cartesian axes, containing an accessible window of 5.7 \u00d7 5.7 \u00c5, which accounts for the protrusion of fluorine into the apertures due to the above-mentioned linker rotation. YCM-101 is isoreticular with our previously reported YCM-23, derived from 2,5-thiophene dicarboxylic acid and InCl3; however, it is topologically distinct from MIL-68-In, synthesized from terephthalic acid and containing an identical infinite chain SBU. Like YCM-23, YCM-101 suffers from stability issues upon complete removal of solvent from the pores. The obtained BET surface areas were inconsistent and irreproducible, ranging from 50 to 200 m2/g.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>(a) Synthesis of YCM-101. (b) Alternative view of YCM-101.\n(c)\nAlternative view of YCM-101. (d) Cartoon and ChemDraw of SBU.</p>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"cg-2016-00488x_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  (a) Synthesis of YCM-101. (b) Alternative view of YCM-101. (c) Alternative view of YCM-101. (d) Cartoon and ChemDraw of SBU.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<p>We hypothesized that the electron\ndeficient arenes of YCM-101 would\nbe capable of \u03c0\u2013\u03c0 stacking with electron rich arenes\nakin to the classic hexafluorobenzene/benzene stacking interaction.\nTo this end we soaked YCM-101 in benzene for 5 days at room temperature\nyielding YCM-101-benzene. Single crystal X-ray diffraction analysis\nindicated a clear \u03c0\u2013\u03c0 stacking interaction of the\nframework with the guest benzene molecules, with a stacking distance\nranging from 3.2 to 3.5 \u00c5 (). Each benzene molecule participates in two distinct\n\u03c0\u2013\u03c0 interactions: a direct stacking interaction\nand a T-shaped interaction with two adjacent perfluorinated linkers.\nAdditionally, when YCM-101 was soaked in a 1% solution of pyridine\nin <italic>i</italic>-PrOH (by volume), direct \u03c0\u2013\u03c0\nstacking interactions of pyridine with the tetrafluoroterephthalate\nlinker were observed via single crystal X-ray diffraction (see <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.6b00488/suppl_file/cg6b00488_si_001.pdf\">Figure S8</ext-link>).</p>", "clean_text": "We hypothesized that the electron deficient arenes of YCM-101 would be capable of \u03c0-\u03c0 stacking with electron rich arenes akin to the classic hexafluorobenzene/benzene stacking interaction. To this end we soaked YCM-101 in benzene for 5 days at room temperature yielding YCM-101-benzene. Single crystal X-ray diffraction analysis indicated a clear \u03c0-\u03c0 stacking interaction of the framework with the guest benzene molecules, with a stacking distance ranging from 3.2 to 3.5 \u00c5 (). Each benzene molecule participates in two distinct \u03c0-\u03c0 interactions: a direct stacking interaction and a T-shaped interaction with two adjacent perfluorinated linkers. Additionally, when YCM-101 was soaked in a 1% solution of pyridine in i-PrOH (by volume), direct \u03c0-\u03c0 stacking interactions of pyridine with the tetrafluoroterephthalate linker were observed via single crystal X-ray diffraction (see Figure S8).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>\u03c0\u2013\u03c0 stacking interactions\nin YCM-101-benzene.</p>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"cg-2016-00488x_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  \u03c0-\u03c0 stacking interactions in YCM-101-benzene.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 12, "type": "text", "classification": "error", "content": "<p>Encouraged by these initial\nresults, we sought to apply YCM-101\u2019s\npotential for \u03c0\u2013\u03c0 interactions to the removal of\npharmaceuticals from water. To this end \u223c50 mg of YCM-101 was\ntreated with an aqueous solution containing 10,000 ppm of tetracycline\nhydrochloride for 5 days. At this time the colorless sample of YCM-101\nhad turned a distinct yellow-orange color (the color of tetracycline).\nThe tetracycline doped-MOF was then digested in DCl:CD<sub>3</sub>OD and analyzed by <sup>1</sup>H NMR, which indicated \u223c800\nppm (based on an average of 3 runs) uptake of tetracycline (or 32\nmg of drug per 1 g of MOF. Analysis of the cross section (see <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.6b00488/suppl_file/cg6b00488_si_001.pdf\">Figure S9</ext-link>) of the doped material indicated persistent\nyellow/orange color throughout the crystal demonstrating that tetracycline\nincorporation is not just a surface phenomenon. Additionally, when\nYCM-101 was subjected to a double dosing experiment (two successive\ntreatments of 10,000 ppm tetracycline for 5 days; 20,000 ppm total),\n\u223c800 ppm uptake of tetracycline was observed, indicating that\nthis is the theoretical maximum of the system. Efforts to recycle\nthe MOF for tetracycline uptake were ineffective. Upon treatment with\nwater, DMF, benzene, or anisole at room temperature or heating to\n60 \u00b0C, no tetracycline was removed from the material.</p>", "clean_text": "Encouraged by these initial results, we sought to apply YCM-101's potential for \u03c0-\u03c0 interactions to the removal of pharmaceuticals from water. To this end ~50 mg of YCM-101 was treated with an aqueous solution containing 10,000 ppm of tetracycline hydrochloride for 5 days. At this time the colorless sample of YCM-101 had turned a distinct yellow-orange color (the color of tetracycline). The tetracycline doped-MOF was then digested in DCl:CD3OD and analyzed by 1H NMR, which indicated ~800 ppm (based on an average of 3 runs) uptake of tetracycline (or 32 mg of drug per 1 g of MOF. Analysis of the cross section (see Figure S9) of the doped material indicated persistent yellow/orange color throughout the crystal demonstrating that tetracycline incorporation is not just a surface phenomenon. Additionally, when YCM-101 was subjected to a double dosing experiment (two successive treatments of 10,000 ppm tetracycline for 5 days; 20,000 ppm total), ~800 ppm uptake of tetracycline was observed, indicating that this is the theoretical maximum of the system. Efforts to recycle the MOF for tetracycline uptake were ineffective. Upon treatment with water, DMF, benzene, or anisole at room temperature or heating to 60 \u00b0C, no tetracycline was removed from the material.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<p>To\ntest if the loading of tetracycline into YCM-101 was due to\n\u03c0\u2013\u03c0 stacking as hypothesized, large-pored MIL-68-In\nwas soaked in a 10,000 ppm aqueous solution of tetracycline. Although\nthe MOF underwent a distinctive albeit minor color change from colorless\nto light yellow, indicative of tetracycline incorporation, upon soaking\nwith fresh water at room temperature, NMR analysis of the digested\nMIL-68 postwashing indicated no permanent tetracycline incorporation.\nThese results in conjunction with our benzene doping studies support\nthat tetracycline loading in YCM-101 is due to \u03c0\u2013\u03c0\nstacking interactions of the electron deficient framework with an\nelectron rich substrate.</p>", "clean_text": "To test if the loading of tetracycline into YCM-101 was due to \u03c0-\u03c0 stacking as hypothesized, large-pored MIL-68-In was soaked in a 10,000 ppm aqueous solution of tetracycline. Although the MOF underwent a distinctive albeit minor color change from colorless to light yellow, indicative of tetracycline incorporation, upon soaking with fresh water at room temperature, NMR analysis of the digested MIL-68 postwashing indicated no permanent tetracycline incorporation. These results in conjunction with our benzene doping studies support that tetracycline loading in YCM-101 is due to \u03c0-\u03c0 stacking interactions of the electron deficient framework with an electron rich substrate.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<p>The loading of tetracycline into YCM-101\nis complementary to other\npharmaceutical incorporation methods that have been developed to utilize\nMOFs as drug delivery agents. Methods of pharmaceutical incorporation\nhave included encapsulation during MOF synthesis, covalent tethering\npostsynthesis, and the use of noncovalent interactions postsynthesis such as ionic\nand hydrogen bonding. To our knowledge there has yet to be an example of incorporation\nof a drug molecule utilizing \u03c0\u2013\u03c0 stacking interactions\nwith an electron deficient framework and an electron rich drug molecule.</p>", "clean_text": "The loading of tetracycline into YCM-101 is complementary to other pharmaceutical incorporation methods that have been developed to utilize MOFs as drug delivery agents. Methods of pharmaceutical incorporation have included encapsulation during MOF synthesis, covalent tethering postsynthesis, and the use of noncovalent interactions postsynthesis such as ionic and hydrogen bonding. To our knowledge there has yet to be an example of incorporation of a drug molecule utilizing \u03c0-\u03c0 stacking interactions with an electron deficient framework and an electron rich drug molecule.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "text", "classification": ["property"], "content": "<p>PXRD analysis of YCM-101 doped with tetracycline indicated a distinct\nphase change to a new structure hereto referred as YCM-101\u2032.\nSingle crystal X-ray diffraction of this new material indicated a\nchange in the SBU to a new infinite chain [[In\u00ad(\u03bc-O<sub>2</sub>CR)\u00ad(\u03ba<sup>1</sup>-O<sub>2</sub>CR)<sub>2</sub>(\u03bc-OH)]\u00ad[In\u00ad(\u03bc-O<sub>2</sub>CR)\u00ad(H<sub>2</sub>O)<sub>2</sub>(\u03bc-OH)]]<sub>\u221e</sub>, which contains a unique In<sup>1\u2013</sup>\u2013In<sup>1+</sup> repeating pattern (). Each linker has one carboxylate binding the SBU in the\n\u03bc-form and the other carboxylate binding a different infinite\nchain in the \u03ba<sup>1</sup>-form. PLATON calculations show an\nincrease in void volume to 1210 \u00c5<sup>3</sup>. YCM-101\u2032\nis porous along only two Cartesian axes, but the largest pore aperture\nincreases to 6.7 \u00d7 6.3 \u00c5. We hypothesize that this increase\nin aperture size and volume is necessary for tetracycline uptake,\nas when YCM-101 was soaked with tetracycline in DMF, no drug was observed\nupon postreaction analysis. Unfortunately, tetracycline could not\nbe observed crystallographically in YCM-101\u2032; the only molecules\nobserved in the pores are highly disordered residual DMF molecules\ndespite the crystal being soaked in aqueous solution for 5 days.</p>", "clean_text": "PXRD analysis of YCM-101 doped with tetracycline indicated a distinct phase change to a new structure hereto referred as YCM-101'. Single crystal X-ray diffraction of this new material indicated a change in the SBU to a new infinite chain [[In(\u03bc-O2CR)(\u03ba1-O2CR)2(\u03bc-OH)][In(\u03bc-O2CR)(H2O)2(\u03bc-OH)]]\u221e, which contains a unique In1--In1+ repeating pattern (). Each linker has one carboxylate binding the SBU in the \u03bc-form and the other carboxylate binding a different infinite chain in the \u03ba1-form. PLATON calculations show an increase in void volume to 1210 \u00c53. YCM-101' is porous along only two Cartesian axes, but the largest pore aperture increases to 6.7 \u00d7 6.3 \u00c5. We hypothesize that this increase in aperture size and volume is necessary for tetracycline uptake, as when YCM-101 was soaked with tetracycline in DMF, no drug was observed upon postreaction analysis. Unfortunately, tetracycline could not be observed crystallographically in YCM-101'; the only molecules observed in the pores are highly disordered residual DMF molecules despite the crystal being soaked in aqueous solution for 5 days.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 16, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(a) Structure\nof YCM-101\u2032. (b) Alternative view of YCM-101\u2032.\n(c) Cartoon and ChemDraw of SBU.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"cg-2016-00488x_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  (a) Structure of YCM-101'. (b) Alternative view of YCM-101'. (c) Cartoon and ChemDraw of SBU.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "text", "classification": ["else"], "content": "<p>To test if the conversion of YCM-101 to YCM-101\u2032 was\ndependent\non or catalyzed by the presence of tetracycline, YCM-101 was suspended\nin water for 5 days. Strikingly, this reaction does not yield YCM-101\u2032,\nbut a mixture of different phases formed by dissolution and renucleation/crystallization\nin which one of the single crystalline phases is a new MOF referred\nto as YCM-101\u2033 (). YCM-101\u2033 is a one-dimensional framework containing\na cationic infinite chain [In\u00ad(\u03bc-O<sub>2</sub>CR)\u00ad(H<sub>2</sub>O)<sub>2</sub>(\u03bc-OH)]<sub>\u221e</sub> SBU. Each linker has\none carboxylate bound to the SBU and one unbound carboxylate representing\nthe charge balancing anion. Notably the cationic In center in YCM-101\u2033\nis distinct from the cationic In center in YCM-101\u2032. In YCM-101\u2032,\nthe H<sub>2</sub>O ligands are in a <italic>cis</italic> arrangement,\nwhile in YCM-101\u2033 they are in a <italic>trans</italic> arrangement.\nYCM-101\u2033 is not porous in any of the Cartesian axes, fully\nsupported by the failure of YCM-101\u2033 to uptake tetracycline.</p>", "clean_text": "To test if the conversion of YCM-101 to YCM-101' was dependent on or catalyzed by the presence of tetracycline, YCM-101 was suspended in water for 5 days. Strikingly, this reaction does not yield YCM-101', but a mixture of different phases formed by dissolution and renucleation/crystallization in which one of the single crystalline phases is a new MOF referred to as YCM-101\" (). YCM-101\" is a one-dimensional framework containing a cationic infinite chain [In(\u03bc-O2CR)(H2O)2(\u03bc-OH)]\u221e SBU. Each linker has one carboxylate bound to the SBU and one unbound carboxylate representing the charge balancing anion. Notably the cationic In center in YCM-101\" is distinct from the cationic In center in YCM-101'. In YCM-101', the H2O ligands are in a cis arrangement, while in YCM-101\" they are in a trans arrangement. YCM-101\" is not porous in any of the Cartesian axes, fully supported by the failure of YCM-101\" to uptake tetracycline.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 18, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>(a) Structure\nof YCM-101\u2033. (b) Side-on view of single 1-D\nstrand. (c) Cartoon and chemical sketch of SBU.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"cg-2016-00488x_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  (a) Structure of YCM-101\". (b) Side-on view of single 1-D strand. (c) Cartoon and chemical sketch of SBU.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<p>The conversion of YCM-101 to YCM-101\u2032 and YCM-101\u2033\nis surprising given the literature precedence for the hydrophobicity\nof fluorinated MOFs. However, computational and experimental studies\nhave linked the hydrophobicity of perfluorinated organics to the relative\n\u201cfatness\u201d of the perfluorinated system compared to the\nperhydro counterpart, the effects of which are proportional to the\nnumber of C\u2013F bonds. YCM-101 has\nonly four C\u2013F bonds per linker potentially leading to the lack\nof hydrophobicity. Correspondingly, the perfluorinated terephthalic\nacid linker is an excellent leaving group due to stabilization of\nthe leaving anion, leading to the facile hydrolysis of the YCM-101\nSBU to yield YCM-101\u2032 and YCM-101\u2033, respectively.</p>", "clean_text": "The conversion of YCM-101 to YCM-101' and YCM-101\" is surprising given the literature precedence for the hydrophobicity of fluorinated MOFs. However, computational and experimental studies have linked the hydrophobicity of perfluorinated organics to the relative \"fatness\" of the perfluorinated system compared to the perhydro counterpart, the effects of which are proportional to the number of C-F bonds. YCM-101 has only four C-F bonds per linker potentially leading to the lack of hydrophobicity. Correspondingly, the perfluorinated terephthalic acid linker is an excellent leaving group due to stabilization of the leaving anion, leading to the facile hydrolysis of the YCM-101 SBU to yield YCM-101' and YCM-101\", respectively.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 20, "type": "text", "classification": ["else"], "content": "<title>Conclusion</title><p>In conclusion, this article has described an alternative strategy\nfor drug incorporation into MOFs via putative \u03c0\u2013\u03c0\nstacking interactions. This new strategy is envisioned to be applicable\nfor the removal of pharmaceuticals from water streams, as was demonstrated\nby the removal of tetracycline from aqueous solution using the new\nIn-derived perfluorinated MOF YCM-101. Due to the inherent instability\nof YCM-101, perfluorinated MOFs with more attractive hydrophobicities\nare under investigation; those results will be reported when appropriate.</p>", "clean_text": "Conclusion\n\nIn conclusion, this article has described an alternative strategy for drug incorporation into MOFs via putative \u03c0-\u03c0 stacking interactions. This new strategy is envisioned to be applicable for the removal of pharmaceuticals from water streams, as was demonstrated by the removal of tetracycline from aqueous solution using the new In-derived perfluorinated MOF YCM-101. Due to the inherent instability of YCM-101, perfluorinated MOFs with more attractive hydrophobicities are under investigation; those results will be reported when appropriate.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<p>The Supporting\nInformation\nis available free of charge on the <ext-link xlink:href=\"http://pubs.acs.org\">ACS Publications website</ext-link> at DOI: <ext-link xlink:href=\"http://pubs.acs.org/doi/abs/10.1021/acs.cgd.6b00488\">10.1021/acs.cgd.6b00488</ext-link>.<list id=\"silist\" list-type=\"label\">\n<list-item>\n<p>Full experimental\ndetails, spectra, and diffractograms\n(<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.6b00488/suppl_file/cg6b00488_si_001.pdf\">PDF</ext-link>)</p>\n</list-item>\n</list>\n</p><p>Full experimental\ndetails, spectra, and diffractograms\n(<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.6b00488/suppl_file/cg6b00488_si_001.pdf\">PDF</ext-link>)</p><p>CCDC <ext-link ext-link-type=\"ccdc\" xlink:href=\"1457968\">1457968</ext-link>\u2013<ext-link ext-link-type=\"ccdc\" xlink:href=\"1457972\">1457972</ext-link> contains the supplementary crystallographic data\nfor this paper. These data can be obtained free of charge via <ext-link xlink:href=\"http://www.ccdc.cam.ac.uk/data_request/cif\">www.ccdc.cam.ac.uk/data_request/cif</ext-link>, or by emailing <email>data_request@ccdc.cam.ac.uk</email>, or by\ncontacting The Cambridge Crystallographic Data Centre, 12, Union Road,\nCambridge CB2 1EZ, UK; fax: +44 1223 336033.</p>", "clean_text": "The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.cgd.6b00488.  Full experimental details, spectra, and diffractograms (PDF)   \n\nFull experimental details, spectra, and diffractograms (PDF)\n\nCCDC 1457968-1457972 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 22, "type": "text", "classification": ["else"], "content": "<p>We thank YSU\nChemistry Department, STEM College, and Graduate School for start-up\nfunds. The X-ray diffractometers were funded by NSF Grants CHE 0087210\nand DMR 1337296, by Ohio Board of Regents Grant CAP-491, and by Youngstown\nState University.</p>", "clean_text": "We thank YSU Chemistry Department, STEM College, and Graduate School for start-up funds. The X-ray diffractometers were funded by NSF Grants CHE 0087210 and DMR 1337296, by Ohio Board of Regents Grant CAP-491, and by Youngstown State University.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 23, "type": "text", "classification": ["else"], "content": "<p>The authors\ndeclare the following competing financial interest(s): US Provisional\nPat. App. No 62/280,769 has been filed by Youngstown State University.</p><title>References</title>", "clean_text": "The authors declare the following competing financial interest(s): US Provisional Pat. App. No 62/280,769 has been filed by Youngstown State University.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": 6, "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of YCM-101</title><p>To a premixed solution of DMF\n(4.75 mL), 2-propanol (85.50 mL), and deionized water (4.75 mL) was\nadded 2,3,5,6-tetrafluoroterephthalic acid (0.595 g, 2.50 mmol, 1.00\nequiv) and InCl<sub>3</sub> (1.10 g, 5.00 mmol, 2.00 equiv) in that\norder. The resulting solution was sonicated for 6\u20137 min until\ncomplete dissolution was observed. The solution sat in a hood for\n30 min covered with Parafilm, which was determined to produce larger\ncrystals than no wait period. The clear solution was then filtered\nthrough a GE-brand 25 mm PVDF syringe filter in 5 mL portions into\n20 mL scintillation vials. The scintillation vials were sealed with\nTeflon-lined caps and placed in an 80 \u00b0C oven for 72 h. The vials\nwere removed from the oven and allowed to cool to room temperature.\nThe cubic, colorless crystals were combined into one 4 mL vial by\ndrawing up both crystals and mother liquor using a pipet. The mother\nliquor was decanted away from the crystals, which were then washed\nwith DMF (3 \u00d7 2 mL). Crystals of YCM-101 washed with DMF (3 \u00d7\n2 mL) were dried under high vacuum at room temperature for a minimum\nof 18 h yielding \u201cactivated YCM-101\u201d.</p>", "clean_text": "Synthesis of YCM-101\n\nTo a premixed solution of DMF (4.75 mL), 2-propanol (85.50 mL), and deionized water (4.75 mL) was added 2,3,5,6-tetrafluoroterephthalic acid (0.595 g, 2.50 mmol, 1.00 equiv) and InCl3 (1.10 g, 5.00 mmol, 2.00 equiv) in that order. The resulting solution was sonicated for 6-7 min until complete dissolution was observed. The solution sat in a hood for 30 min covered with Parafilm, which was determined to produce larger crystals than no wait period. The clear solution was then filtered through a GE-brand 25 mm PVDF syringe filter in 5 mL portions into 20 mL scintillation vials. The scintillation vials were sealed with Teflon-lined caps and placed in an 80 \u00b0C oven for 72 h. The vials were removed from the oven and allowed to cool to room temperature. The cubic, colorless crystals were combined into one 4 mL vial by drawing up both crystals and mother liquor using a pipet. The mother liquor was decanted away from the crystals, which were then washed with DMF (3 \u00d7 2 mL). Crystals of YCM-101 washed with DMF (3 \u00d7 2 mL) were dried under high vacuum at room temperature for a minimum of 18 h yielding \"activated YCM-101\".", "data": [[{"meta": {"name": "YCM-101", "symbol": "", "chemical formula": ""}, "processes": [{"synthesis method": "sonochemical synthesis", "precursor": [{"name": "2,3,5,6-tetrafluoroterephthalic acid", "amount": "0.595", "unit": "g"}, {"name": "InCl3", "amount": "1.10", "unit": "g"}], "solvent": [{"name": "DMF", "amount": "4.75", "unit": "mL"}, {"name": "2-propanol", "amount": "85.50", "unit": "mL"}, {"name": "deionized water", "amount": "4.75", "unit": "mL"}], "temperature": "", "ultrasonic frequency": "", "power": "", "time": "6-7 min"}, {"synthesis method": "resting", "time": "30 min", "atmosphere": "hood", "cover": "Parafilm"}, {"synthesis method": "filtration", "time": "", "atmosphere": "", "pressure": ""}, {"synthesis method": "solvothermal synthesis", "temperature": "80 \u00b0C", "time": "72 h"}, {"synthesis method": "cooling", "temperature": "room temperature", "time": ""}, {"synthesis method": "washing", "washing solution": "DMF", "amount": "3 \u00d7 2 mL"}, {"synthesis method": "drying", "pressure": "high vacuum", "temperature": "room temperature", "atmosphere": "", "time": "minimum of 18 h"}], "yield": "", "other properties": ["activated YCM-101", "cubic, colorless crystals"]}]], "include_properties": ["sonochemical_synthesis", "drying", "filtration", "washing"], "intermediate_step": {"text-synthesis-type": "['sonochemical_synthesis', 'filtration', 'washing', 'drying']", "text-synthesis-struct": "```JSON\n[{\"meta\":{\"name\":\"YCM-101\", \"symbol\":\"\", \"chemical formula\":\"\"}, \"processes\": [{\"synthesis method\": \"sonochemical synthesis\", \"precursor\":[{\"name\":\"2,3,5,6-tetrafluoroterephthalic acid\", \"amount\":\"0.595\", \"unit\":\"g\"}, {\"name\":\"InCl3\", \"amount\":\"1.10\", \"unit\":\"g\"}], \"solvent\":[{\"name\":\"DMF\", \"amount\":\"4.75\", \"unit\":\"mL\"}, {\"name\":\"2-propanol\", \"amount\":\"85.50\", \"unit\":\"mL\"}, {\"name\":\"deionized water\", \"amount\":\"4.75\", \"unit\":\"mL\"}], \"temperature\":\"\", \"ultrasonic frequency\":\"\", \"power\":\"\", \"time\":\"6-7 min\"}, {\"synthesis method\": \"resting\", \"time\":\"30 min\", \"atmosphere\":\"hood\", \"cover\":\"Parafilm\"}, {\"synthesis method\": \"filtration\", \"time\":\"\", \"atmosphere\":\"\", \"pressure\":\"\"}, {\"synthesis method\": \"solvothermal synthesis\", \"temperature\":\"80 \u00b0C\", \"time\":\"72 h\"}, {\"synthesis method\": \"cooling\", \"temperature\":\"room temperature\", \"time\":\"\"}, {\"synthesis method\": \"washing\", \"washing solution\":\"DMF\", \"amount\":\"3 \u00d7 2 mL\"}, {\"synthesis method\": \"drying\", \"pressure\":\"high vacuum\", \"temperature\":\"room temperature\", \"atmosphere\":\"\", \"time\":\"minimum of 18 h\"}], \"yield\": \"\", \"other properties\": [\"activated YCM-101\", \"cubic, colorless crystals\"]}]\n```"}}, {"idx": 15, "type": "text", "classification": "property", "content": "<p>PXRD analysis of YCM-101 doped with tetracycline indicated a distinct\nphase change to a new structure hereto referred as YCM-101\u2032.\nSingle crystal X-ray diffraction of this new material indicated a\nchange in the SBU to a new infinite chain [[In\u00ad(\u03bc-O<sub>2</sub>CR)\u00ad(\u03ba<sup>1</sup>-O<sub>2</sub>CR)<sub>2</sub>(\u03bc-OH)]\u00ad[In\u00ad(\u03bc-O<sub>2</sub>CR)\u00ad(H<sub>2</sub>O)<sub>2</sub>(\u03bc-OH)]]<sub>\u221e</sub>, which contains a unique In<sup>1\u2013</sup>\u2013In<sup>1+</sup> repeating pattern (). Each linker has one carboxylate binding the SBU in the\n\u03bc-form and the other carboxylate binding a different infinite\nchain in the \u03ba<sup>1</sup>-form. PLATON calculations show an\nincrease in void volume to 1210 \u00c5<sup>3</sup>. YCM-101\u2032\nis porous along only two Cartesian axes, but the largest pore aperture\nincreases to 6.7 \u00d7 6.3 \u00c5. We hypothesize that this increase\nin aperture size and volume is necessary for tetracycline uptake,\nas when YCM-101 was soaked with tetracycline in DMF, no drug was observed\nupon postreaction analysis. Unfortunately, tetracycline could not\nbe observed crystallographically in YCM-101\u2032; the only molecules\nobserved in the pores are highly disordered residual DMF molecules\ndespite the crystal being soaked in aqueous solution for 5 days.</p>", "clean_text": "PXRD analysis of YCM-101 doped with tetracycline indicated a distinct phase change to a new structure hereto referred as YCM-101'. Single crystal X-ray diffraction of this new material indicated a change in the SBU to a new infinite chain [[In(\u03bc-O2CR)(\u03ba1-O2CR)2(\u03bc-OH)][In(\u03bc-O2CR)(H2O)2(\u03bc-OH)]]\u221e, which contains a unique In1--In1+ repeating pattern (). Each linker has one carboxylate binding the SBU in the \u03bc-form and the other carboxylate binding a different infinite chain in the \u03ba1-form. PLATON calculations show an increase in void volume to 1210 \u00c53. YCM-101' is porous along only two Cartesian axes, but the largest pore aperture increases to 6.7 \u00d7 6.3 \u00c5. We hypothesize that this increase in aperture size and volume is necessary for tetracycline uptake, as when YCM-101 was soaked with tetracycline in DMF, no drug was observed upon postreaction analysis. Unfortunately, tetracycline could not be observed crystallographically in YCM-101'; the only molecules observed in the pores are highly disordered residual DMF molecules despite the crystal being soaked in aqueous solution for 5 days.", "data": [[[{"meta": {"name": "YCM-101'", "symbol": "", "chemical formula": ""}, "pore diameter": [{"value": "6.7", "unit": "\u00c5", "condition": ""}, {"value": "6.3", "unit": "\u00c5", "condition": ""}]}]]], "include_properties": ["pore_diameter"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['pore_diameter']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"YCM-101'\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"pore diameter\": [\n            {\n                \"value\": \"6.7\",\n                \"unit\": \"\u00c5\",\n                \"condition\": \"\"\n            },\n            {\n                \"value\": \"6.3\",\n                \"unit\": \"\u00c5\",\n                \"condition\": \"\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>(a) Synthesis of YCM-101. (b) Alternative view of YCM-101.\n(c)\nAlternative view of YCM-101. (d) Cartoon and ChemDraw of SBU.</p>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"cg-2016-00488x_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  (a) Synthesis of YCM-101. (b) Alternative view of YCM-101. (c) Alternative view of YCM-101. (d) Cartoon and ChemDraw of SBU.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 11, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>\u03c0\u2013\u03c0 stacking interactions\nin YCM-101-benzene.</p>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"cg-2016-00488x_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  \u03c0-\u03c0 stacking interactions in YCM-101-benzene.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 16, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(a) Structure\nof YCM-101\u2032. (b) Alternative view of YCM-101\u2032.\n(c) Cartoon and ChemDraw of SBU.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"cg-2016-00488x_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  (a) Structure of YCM-101'. (b) Alternative view of YCM-101'. (c) Cartoon and ChemDraw of SBU.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>(a) Structure\nof YCM-101\u2033. (b) Side-on view of single 1-D\nstrand. (c) Cartoon and chemical sketch of SBU.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"cg-2016-00488x_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  (a) Structure of YCM-101\". (b) Side-on view of single 1-D strand. (c) Cartoon and chemical sketch of SBU.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/acs.cgd.6b00488", "title": "\nRemoval of Pharmaceuticals from Water via \u03c0\u2013\u03c0\nStacking Interactions in Perfluorinated Metal\u2013Organic Frameworks\n", "journal": "American Chemical\nSociety", "date": "2016.05", "author_list": ["DeFuria\nMariah\nD.", "Zeller\nMatthias", "Genna\nDouglas T."]}}